FdaApplication
NDA 211617
Identifiers
- fda_app_no: NDA211617
Properties
| Property | Value |
|---|---|
| applicant_name | ESPERION THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2020-02-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXLIZET | BEMPEDOIC ACID; EZETIMIBE | 180MG;10MG | TABLET;ORAL |
1 product